المؤلفون: Slotman E; Technical Medical Centre, Department of Health Technology and Services Research, University of Twente, Enschede, Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.; Netherlands Association for Palliative Care, Utrecht, Netherlands., Weijzen F; Technical Medical Centre, Department of Health Technology and Services Research, University of Twente, Enschede, Netherlands., Fransen HP; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.; Netherlands Association for Palliative Care, Utrecht, Netherlands., van Hoeve JC; Technical Medical Centre, Department of Health Technology and Services Research, University of Twente, Enschede, Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands., Huijben AMT; Department of Internal Medicine, Maasstad Hospital, Rotterdam, Netherlands., Kuip EJM; Department of Medical Oncology and Department of Anesthesiology, Pain and Palliative Care, Radboud Medical Center, Nijmegen, Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands., Kunst PWA; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.; Department of Pulmonology, Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands., van Laarhoven HWM; Medical Oncology, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands.; Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, Netherlands., Tol J; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, Research Institute GROW, Maastricht University Medical Centre, Maastricht, Netherlands., Raijmakers NJH; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.; Netherlands Association for Palliative Care, Utrecht, Netherlands., van der Linden YM; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.; Department of Radiotherapy, Leiden University Medical Centre, Leiden, Netherlands.; Centre of Expertise in Palliative Care, Leiden University Medical Centre, Leiden, Netherlands., Siesling S; Technical Medical Centre, Department of Health Technology and Services Research, University of Twente, Enschede, Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.

مؤلفون مشاركون: On-behalf-of-the-COVID-and-Cancer-NL Consortium

المصدر: International journal of cancer [Int J Cancer] 2024 May 15; Vol. 154 (10), pp. 1786-1793. Date of Electronic Publication: 2024 Jan 24.

نوع المنشور: Observational Study; Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19* , Neoplasms*, Humans ; Pandemics ; Continuity of Patient Care

المؤلفون: van Maaren MC; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, P.O. Box 217, 7500 AE, Enschede, the Netherlands. m.c.vanmaaren@utwente.nl.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands. m.c.vanmaaren@utwente.nl., van Hoeve JC; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, P.O. Box 217, 7500 AE, Enschede, the Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., Korevaar JC; Netherlands Institute for Health Services Research (NIVEL), Utrecht, the Netherlands.; The Hague University of Applied Sciences, The Hague, the Netherlands., van Hezewijk M; Institution for Radiation Oncology, Arnhem, the Netherlands., Siemerink EJM; Department of Internal Medicine, ZGT, Hengelo, the Netherlands., Zeillemaker AM; Department of Surgery, Alrijne Hospital, Leiden, the Netherlands., Klaassen-Dekker A; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, P.O. Box 217, 7500 AE, Enschede, the Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., van Uden DJP; Department of Surgery, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands., Volders JH; Department of Surgery, Diakonessenhuis, Utrecht, the Netherlands., Drossaert CHC; Department of Psychology, Health & Technology, University of Twente, Enschede, the Netherlands., Siesling S; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, P.O. Box 217, 7500 AE, Enschede, the Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.

مؤلفون مشاركون: NABOR project group

المصدر: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 May 02; Vol. 32 (5), pp. 323. Date of Electronic Publication: 2024 May 02.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Systematic Review

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Aftercare*/methods , Breast Neoplasms*/therapy, Female ; Humans ; Cost-Benefit Analysis ; Follow-Up Studies ; Precision Medicine/methods

المؤلفون: Wolfkamp W; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.; Department of Health Technology and Services Research, University of Twente, Enschede, the Netherlands., Meijer J; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.; Department of Health Technology and Services Research, University of Twente, Enschede, the Netherlands., van Hoeve JC; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.; Department of Health Technology and Services Research, University of Twente, Enschede, the Netherlands., van Erning F; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.; Department of Surgical Oncology, Catharina Cancer Institute, Eindhoven, the Netherlands., de Geus-Oei LF; Department of Radiology, Leiden University Medical Center (LUMC), Leiden, the Netherlands.; Biomedical Photonic Imaging Group, University of Twente, Enschede, the Netherlands.; Department of Radiation Science & Technology, Delft University of Technology, Delft, the Netherlands., de Hingh I; Department of Surgical Oncology, Catharina Cancer Institute, Eindhoven, the Netherlands.; Department of Knowledge and Advice, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.; Department of Epidemiology, GROW-School for Oncology Reproduction, Maastricht University, Maastricht, The Netherlands., Veltman J; Biomedical Photonic Imaging Group, University of Twente, Enschede, the Netherlands.; Department of Radiology, ZGT, Almelo, the Netherlands., Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.; Department of Health Technology and Services Research, University of Twente, Enschede, the Netherlands.

مؤلفون مشاركون: COVID and Cancer‐NL Consortium

المصدر: Cancer medicine [Cancer Med] 2024 Jan; Vol. 13 (1), pp. e6861. Date of Electronic Publication: 2024 Jan 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/epidemiology , Colorectal Neoplasms*/epidemiology , Colorectal Neoplasms*/diagnosis , Breast Neoplasms*/epidemiology , Breast Neoplasms*/diagnosis , Breast Neoplasms*/diagnostic imaging, Humans ; Netherlands/epidemiology ; Female ; Male ; Middle Aged ; Aged ; SARS-CoV-2 ; Registries ; Mammography/statistics & numerical data ; Early Detection of Cancer/statistics & numerical data ; Early Detection of Cancer/methods ; Critical Pathways ; Adult

المؤلفون: van Hoeve JC; University of Twente, Health Technology and Services Research, Enschede, the Netherlands; Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands. Electronic address: j.vanhoeve@iknl.nl., Verhoeven RHA; Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., Nagengast WB; University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Oppedijk V; Radiotherapy Institute Friesland, Leeuwarden, the Netherlands., Lynch MG; Gelre Hospitals, Apeldoorn, the Netherlands., van Rooijen JM; Martini Hospital, Groningen, the Netherlands., Veldhuis P; Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., Siesling S; University of Twente, Health Technology and Services Research, Enschede, the Netherlands; Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., Kouwenhoven EA; Hospital Group Twente, Almelo, the Netherlands.

المصدر: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2023 Jan; Vol. 49 (1), pp. 106-112. Date of Electronic Publication: 2022 Aug 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8504356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2157 (Electronic) Linking ISSN: 07487983 NLM ISO Abbreviation: Eur J Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Esophageal Neoplasms*, Humans ; Treatment Outcome ; Combined Modality Therapy ; Hospitals ; Netherlands/epidemiology

المؤلفون: Lawler M; Patrick G Johnston Centre for Cancer Research, Faculty of Medicine, Health and Life Sciences, Queen's University Belfast, Belfast, UK. Electronic address: mark.lawler@qub.ac.uk., Davies L; International Cancer Research Partnership, International House, Cardiff, UK., Oberst S; Organisation of European Cancer Institutes, Brussels, Belgium., Oliver K; International Brain Tumour Alliance, Tadworth, UK; European Cancer Organisation Patient Advisory Committee, Brussels, Belgium., Eggermont A; Faculty of Medicine, Utrecht University Medical Center, Utrecht, Netherlands; Princess Máxima Centrum, Utrecht, Netherlands., Schmutz A; International Agency for Cancer Research, Lyon, France., La Vecchia C; Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy., Allemani C; Cancer Survival Group, London School of Hygiene & Tropical Medicine, London, UK., Lievens Y; Department of Radiation Oncology, Ghent University and Ghent University Hospital, Ghent, Belgium., Naredi P; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Cufer T; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Aggarwal A; Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, UK; Institute of Cancer Policy, King's College London, London, UK; Guy's and St Thomas' NHS Foundation Trust, London, UK., Aapro M; Genolier Cancer Center, Genolier, Switzerland., Apostolidis K; Hellenic Cancer Federation, Athens, Greece; European Cancer Patient Coalition, Brussels, Belgium., Baird AM; Lung Cancer Europe, Bern, Switzerland; Trinity Translational Medicine Institute, Trinity College Dublin, Dublin, Ireland., Cardoso F; Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal., Charalambous A; European Cancer Organisation Brussels, Brussels, Belgium; Department of Nursing, Cyprus University of Technology, Limassol, Cyprus; Department of Oncology, University of Turku, Turku, Finland., Coleman MP; Cancer Survival Group, London School of Hygiene & Tropical Medicine, London, UK., Costa A; European School of Oncology, Milan, Italy., Crul M; Amsterdam UMC, Amsterdam, Netherlands., Dégi CL; Faculty of Sociology and Social Work, Babeș-Bolyai University, Cluj-Napoca, Romania., Di Nicolantonio F; Department of Oncology, University of Turin, Turin, Italy; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Erdem S; European Cancer Organisation Patient Advisory Committee, Europa Donna, Istanbul, Türkiye., Geanta M; Centre for Innovation in Medicine and Kol Medical Media, Bucharest, Romania., Geissler J; Patvocates and CML Advocates Network, Leukaemie-Online (LeukaNET), Munich, Germany., Jassem J; Medical University of Gdańsk, Gdańsk, Poland., Jagielska B; Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Jonsson B; Stockholm School of Economics, Stockholm, Sweden., Kelly D; School of Healthcare Sciences, Cardiff University, Cardiff, UK., Kelm O; International Agency for Research on Cancer, Lyon, France., Kolarova T; International Neuroendocrine Cancer Alliance, Boston, MA, USA., Kutluk T; Faculty of Medicine & Cancer Institute, Hacettepe University, Ankara, Türkiye., Lewison G; Institute of Cancer Policy, School of Cancer Sciences, Kings College London, London, UK., Meunier F; Belgian Royal Academy of Medicine, Brussels, Belgium., Pelouchova J; Diagnoza leukemie, Prague, Czech Republic., Philip T; Organisation of European Cancer Institutes, Brussels, Belgium; Institut Curie, Paris, France., Price R; European Cancer Organisation Brussels, Brussels, Belgium., Rau B; Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Rubio IT; Cancer Center, University of Navarra, Madrid, Spain., Selby P; School of Medicine, University of Leeds, Leeds, UK., Južnič Sotlar M; EuropaColon Slovenia, Ljubljana, Slovenia., Spurrier-Bernard G; Melanoma Patient Network Europe, Brussels, Belgium., van Hoeve JC; Organisation of European Cancer Institutes, Brussels, Belgium; Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands., Vrdoljak E; Department of Oncology, University Hospital Center Split, School of Medicine, University of Split, Split, Croatia., Westerhuis W; Organisation of European Cancer Institutes, Brussels, Belgium; Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands., Wojciechowska U; Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Sullivan R; Institute of Cancer Policy, School of Cancer Sciences, Kings College London, London, UK.

المصدر: The Lancet. Oncology [Lancet Oncol] 2023 Jan; Vol. 24 (1), pp. e11-e56. Date of Electronic Publication: 2022 Nov 16.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/epidemiology , Neoplasms*/diagnosis , Neoplasms*/epidemiology , Neoplasms*/therapy, Humans ; Pandemics ; Health Services Research ; Europe/epidemiology ; Europe, Eastern

المؤلفون: Meijer J; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, the Netherlands., Elferink MAG; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., van Hoeve JC; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, the Netherlands., Buijsen J; Department of Radiation Oncology (Maastro), GROW School for Oncology, Maastricht University Medical Center, Maastricht, the Netherlands., van Erning F; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., Nagtegaal ID; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Tanis PJ; Department of Surgery, Cancer Centre Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Vink GR; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Wumkes ML; Department of Medical Oncology, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., de Hingh IHJT; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands; Department of Surgery, Catharina Cancer Institute-Catharina Hospital, Eindhoven, the Netherlands., Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, the Netherlands. Electronic address: s.siesling@utwente.nl.

مؤلفون مشاركون: On-behalf-of-the-COVID-and-Cancer-NL Consortium

المصدر: Clinical colorectal cancer [Clin Colorectal Cancer] 2022 Sep; Vol. 21 (3), pp. e171-e178. Date of Electronic Publication: 2022 Mar 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/epidemiology , Colonic Neoplasms*/epidemiology , Colorectal Neoplasms*/diagnosis , Colorectal Neoplasms*/epidemiology , Colorectal Neoplasms*/therapy , Intestinal Obstruction*, Humans ; Netherlands/epidemiology ; Pandemics

المؤلفون: Ankersmid JW; Department of Health Technology and Services Research, Technical Medical Center, University of Twente, Enschede, The Netherlands.; Santeon Hospital Group, Utrecht, The Netherlands., van Hoeve JC; Department of Health Technology and Services Research, Technical Medical Center, University of Twente, Enschede, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Strobbe LJA; Department of Surgery, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands., van Riet YEA; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands., van Uden-Kraan CF; Santeon Hospital Group, Utrecht, The Netherlands., Siesling S; Department of Health Technology and Services Research, Technical Medical Center, University of Twente, Enschede, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Drossaert CHC; Department of Psychology, Health and Technology, University of Twente, Enschede, The Netherlands.

مؤلفون مشاركون: Santeon VBHC Breast Cancer Group

المصدر: European journal of cancer care [Eur J Cancer Care (Engl)] 2021 Nov; Vol. 30 (6), pp. e13505. Date of Electronic Publication: 2021 Aug 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 9301979 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2354 (Electronic) Linking ISSN: 09615423 NLM ISO Abbreviation: Eur J Cancer Care (Engl)

مواضيع طبية MeSH: Breast Neoplasms*/therapy, Aftercare ; Decision Making, Shared ; Female ; Follow-Up Studies ; Health Personnel ; Humans

المؤلفون: van Hoeve JC; Department Health Technology & Services Research, University of Twente, Enschede, the Netherlands. j.c.vanhoeve@utwente.nl.; Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands. j.c.vanhoeve@utwente.nl., Vernooij RWM; Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Fiander M; College of Pharmacy, Department of Pharmacology, University of Utah, Salt Lake City, USA., Nieboer P; Wilhelmina Hospital, Assen, the Netherlands., Siesling S; Department Health Technology & Services Research, University of Twente, Enschede, the Netherlands.; Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands., Rotter T; School of Nursing, Queen's University, Kingston, Canada.

المصدر: Systematic reviews [Syst Rev] 2020 Oct 25; Vol. 9 (1), pp. 246. Date of Electronic Publication: 2020 Oct 25.

نوع المنشور: Journal Article; Meta-Analysis; Systematic Review

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101580575 Publication Model: Electronic Cited Medium: Internet ISSN: 2046-4053 (Electronic) Linking ISSN: 20464053 NLM ISO Abbreviation: Syst Rev Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/therapy , Secondary Care*, Delivery of Health Care ; Humans ; Length of Stay ; Medical Oncology

المؤلفون: van Hoeve JC; Department Health Technology and Services Research (HTSR), University of Twente, P.O. Box 217, 7500 AE, Enschede, the Netherlands. j.c.vanhoeve@utwente.nl.; Netherlands Comprehensive Cancer Organisation (IKNL), P.O. Box 19079, 3501 DB, Utrecht, the Netherlands. j.c.vanhoeve@utwente.nl., Vernooij RWM; Netherlands Comprehensive Cancer Organisation (IKNL), P.O. Box 19079, 3501 DB, Utrecht, the Netherlands., Lawal AK; College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada., Fiander M; College of Pharmacy, Department of Pharmacology, University of Utah, Salt Lake City, USA., Nieboer P; Wilhelmina Hospital, Assen, the Netherlands., Siesling S; Department Health Technology and Services Research (HTSR), University of Twente, P.O. Box 217, 7500 AE, Enschede, the Netherlands.; Netherlands Comprehensive Cancer Organisation (IKNL), P.O. Box 19079, 3501 DB, Utrecht, the Netherlands., Rotter T; Healthcare Quality Programs, School of Nursing, Queen's University, Kingston, Ontario, Canada.

المصدر: Systematic reviews [Syst Rev] 2018 Mar 27; Vol. 7 (1), pp. 49. Date of Electronic Publication: 2018 Mar 27.

نوع المنشور: Journal Article; Meta-Analysis; Review

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101580575 Publication Model: Electronic Cited Medium: Internet ISSN: 2046-4053 (Electronic) Linking ISSN: 20464053 NLM ISO Abbreviation: Syst Rev Subsets: MEDLINE

مواضيع طبية MeSH: Continuity of Patient Care* , Critical Pathways* , Medical Oncology* , Primary Health Care* , Secondary Care*, Delivery of Health Care, Integrated/methods ; Efficiency, Organizational ; Health Care Costs ; Humans

المؤلفون: van Hoeve JC; Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands, j.vanhoeve@iknl.nl., Elferink MA, Klaase JM, Kouwenhoven EA, Schiphorst PP, Siesling S

المصدر: International journal of colorectal disease [Int J Colorectal Dis] 2015 Jun; Vol. 30 (6), pp. 787-95. Date of Electronic Publication: 2015 Apr 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 8607899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1262 (Electronic) Linking ISSN: 01791958 NLM ISO Abbreviation: Int J Colorectal Dis Subsets: MEDLINE

مواضيع طبية MeSH: Critical Pathways*, Rectal Neoplasms/*diagnosis , Rectal Neoplasms/*surgery, Biopsy ; Evidence-Based Medicine ; Hospital Administration ; Humans ; Magnetic Resonance Imaging ; Netherlands ; Organizational Objectives ; Patient Care Team ; Radiotherapy, Adjuvant ; Rectal Neoplasms/radiotherapy ; Time Factors ; Tomography, X-Ray Computed